NPI: 1942226006 · SPRINGFIELD, MA 01104 · Clinical Medical Laboratory · NPI assigned 07/14/2006
Authorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
| Authorized Official | HARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT) |
| NPI Enumeration Date | 07/14/2006 |
Other providers sharing the same authorized official: HARRIS, JAMES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 345,704 | $2.88M |
| 2019 | 440,865 | $3.56M |
| 2020 | 340,600 | $3.10M |
| 2021 | 316,303 | $2.49M |
| 2022 | 292,887 | $2.21M |
| 2023 | 348,368 | $2.39M |
| 2024 | 234,124 | $1.90M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16,738 | 14,352 | $1.03M |
| 87590 | 48,192 | 47,174 | $963K | |
| 87490 | 44,919 | 43,995 | $816K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 39,958 | 38,173 | $711K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 29,896 | 29,602 | $620K |
| 84443 | Thyroid stimulating hormone (TSH) | 72,776 | 68,128 | $611K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 136,485 | 118,006 | $553K |
| 80050 | General health panel | 32,679 | 32,090 | $548K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14,017 | 12,624 | $526K |
| 83036 | Hemoglobin; glycosylated (A1C) | 100,033 | 96,004 | $526K |
| 86481 | 6,953 | 6,768 | $465K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7,086 | 6,933 | $450K |
| 80053 | Comprehensive metabolic panel | 123,816 | 108,442 | $449K |
| 80061 | Lipid panel | 110,968 | 107,309 | $442K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11,297 | 11,047 | $338K |
| 86803 | 26,214 | 25,892 | $299K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,196 | 1,143 | $291K |
| 86780 | 24,957 | 24,454 | $273K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 7,837 | 7,099 | $270K |
| 82607 | 30,272 | 28,884 | $254K | |
| 85027 | 90,425 | 64,639 | $248K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 45,739 | 42,814 | $239K |
| 87660 | 12,788 | 12,540 | $233K | |
| 87510 | 12,805 | 12,551 | $233K | |
| 87480 | 12,788 | 12,535 | $232K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,137 | 4,920 | $232K |
| 87634 | 4,264 | 4,121 | $228K | |
| 83013 | 4,322 | 4,212 | $218K | |
| 82728 | 23,572 | 22,616 | $213K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 95,516 | 69,374 | $194K |
| 87077 | 28,676 | 18,698 | $172K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 7,408 | 6,933 | $165K |
| 87808 | 14,153 | 13,869 | $160K | |
| 87340 | 19,080 | 18,777 | $154K | |
| 87522 | Neg quan hep c or qual rna | 4,358 | 4,236 | $140K |
| 83550 | 24,923 | 23,640 | $136K | |
| 86003 | 3,062 | 2,605 | $136K | |
| 82746 | 15,938 | 15,190 | $130K | |
| 86706 | 15,058 | 14,775 | $126K | |
| 86704 | 12,732 | 12,506 | $119K | |
| 86480 | 2,174 | 2,162 | $119K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 833 | 823 | $119K |
| 86708 | 12,136 | 11,938 | $116K | |
| 83540 | 26,369 | 24,922 | $105K | |
| 87536 | 2,284 | 2,234 | $99K | |
| 84439 | 17,390 | 16,648 | $95K | |
| 84403 | 4,299 | 4,134 | $82K | |
| 84702 | 5,867 | 4,387 | $80K | |
| 84153 | 6,883 | 6,610 | $78K | |
| 87186 | 17,878 | 15,417 | $78K | |
| 86762 | 6,051 | 6,022 | $77K | |
| 86787 | 6,542 | 6,503 | $75K | |
| 87147 | 8,295 | 6,302 | $74K | |
| 82570 | 28,159 | 26,884 | $73K | |
| 82043 | 25,922 | 25,055 | $72K | |
| ATP14 | 31,404 | 26,139 | $71K | |
| 81001 | 38,876 | 36,436 | $69K | |
| 87507 | 311 | 285 | $69K | |
| 87150 | 2,266 | 2,252 | $67K | |
| 87088 | 16,739 | 15,347 | $65K | |
| ATP08 | 36,689 | 23,591 | $62K | |
| 83970 | 4,025 | 3,751 | $62K | |
| 84146 | 3,853 | 3,784 | $60K | |
| 86618 | 5,128 | 5,003 | $59K | |
| 83880 | 4,799 | 4,276 | $58K | |
| 86038 | 6,688 | 6,527 | $57K | |
| 87070 | 8,138 | 7,781 | $55K | |
| 86709 | 6,107 | 6,006 | $53K | |
| 83735 | 16,788 | 14,076 | $51K | |
| 83001 | 3,130 | 3,089 | $48K | |
| 85610 | 39,097 | 15,582 | $47K | |
| 86696 | 2,638 | 2,618 | $44K | |
| 82784 | 7,023 | 5,262 | $44K | |
| 84270 | 2,620 | 2,564 | $44K | |
| 85651 | 17,944 | 16,640 | $42K | |
| 87902 | 384 | 380 | $40K | |
| 84481 | 3,653 | 3,521 | $39K | |
| 87210 | 8,753 | 8,592 | $37K | |
| 80076 | 12,071 | 11,282 | $37K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,272 | 1,091 | $36K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 486 | 411 | $35K |
| 83516 | 2,475 | 2,344 | $34K | |
| 84425 | 2,469 | 2,308 | $34K | |
| 82785 | 2,421 | 2,389 | $31K | |
| 83002 | 1,920 | 1,895 | $30K | |
| 86140 | 9,724 | 8,715 | $30K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 46,696 | 23,502 | $30K |
| 86695 | 2,564 | 2,547 | $29K | |
| 86765 | 2,558 | 2,537 | $29K | |
| 86850 | 3,859 | 3,826 | $28K | |
| 82533 | 2,418 | 2,277 | $27K | |
| 36415 | Collection of venous blood by venipuncture | 133,310 | 85,882 | $27K |
| 0240U | 185 | 185 | $26K | |
| 87581 | 1,014 | 991 | $26K | |
| 87486 | 1,015 | 992 | $26K | |
| 83014 | 4,389 | 4,249 | $26K | |
| ATP17 | 13,056 | 12,991 | $26K | |
| 84460 | 15,285 | 14,707 | $25K | |
| 82652 | 813 | 810 | $25K | |
| 82172 | 2,033 | 1,941 | $25K | |
| 86735 | 2,093 | 2,078 | $24K | |
| 82670 | 1,104 | 1,079 | $24K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 863 | 858 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 862 | 857 | $22K |
| 83883 | 2,582 | 2,407 | $22K | |
| 87081 | 3,593 | 3,564 | $22K | |
| 84450 | 13,553 | 13,057 | $22K | |
| 87209 | 1,634 | 854 | $22K | |
| 86360 | 1,338 | 1,307 | $22K | |
| 83010 | 2,806 | 2,640 | $21K | |
| 82627 | 1,008 | 1,004 | $20K | |
| 83690 | 4,379 | 4,175 | $19K | |
| 82950 | 4,280 | 4,262 | $19K | |
| 86430 | 4,507 | 4,403 | $18K | |
| ATP03 | 5,511 | 5,468 | $18K | |
| 80164 | 4,685 | 4,132 | $18K | |
| 86355 | 1,326 | 1,294 | $17K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 50,669 | 26,090 | $17K |
| 86694 | 1,262 | 1,247 | $16K | |
| 86235 | 495 | 427 | $16K | |
| 86359 | 1,259 | 1,228 | $16K | |
| 86376 | 1,431 | 1,407 | $16K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 40 | 40 | $15K |
| 84550 | 6,683 | 6,248 | $15K | |
| 86900 | 5,138 | 5,087 | $14K | |
| 82565 | 9,622 | 9,071 | $14K | |
| 85730 | 3,615 | 3,452 | $14K | |
| 87517 | 516 | 505 | $14K | |
| 82140 | 3,372 | 2,148 | $14K | |
| 84255 | 899 | 817 | $14K | |
| 84207 | 745 | 693 | $14K | |
| 82465 | 2,967 | 2,929 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 96 | 94 | $14K |
| 82105 | 1,446 | 1,368 | $13K | |
| 85379 | 1,928 | 1,874 | $12K | |
| 84703 | 1,909 | 1,866 | $12K | |
| 87205 | 5,427 | 5,173 | $12K | |
| 86665 | 452 | 406 | $12K | |
| 84630 | 1,741 | 1,559 | $12K | |
| 82150 | 2,895 | 2,760 | $12K | |
| 86334 | 1,215 | 1,135 | $12K | |
| 87338 | 1,111 | 1,097 | $12K | |
| 87255 | 376 | 373 | $11K | |
| 87177 | 1,712 | 924 | $11K | |
| 82977 | 3,910 | 3,763 | $11K | |
| ATP15 | 3,664 | 3,159 | $11K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1,618 | 1,546 | $11K |
| 84165 | 2,148 | 2,034 | $11K | |
| 82040 | 3,439 | 3,331 | $10K | |
| 87046 | 1,236 | 839 | $10K | |
| 87427 | 1,074 | 661 | $10K | |
| 86200 | 993 | 987 | $9K | |
| 83498 | 350 | 349 | $9K | |
| 86769 | 296 | 293 | $9K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 3,363 | 3,130 | $9K |
| 86800 | 738 | 726 | $9K | |
| 86361 | 652 | 642 | $8K | |
| 86364 | 1,073 | 1,053 | $8K | |
| 82378 | 1,098 | 989 | $8K | |
| 83615 | 3,412 | 3,049 | $8K | |
| 82247 | 3,838 | 3,048 | $8K | |
| 81025 | 1,248 | 1,231 | $8K | |
| 86255 | 751 | 746 | $8K | |
| 86160 | 521 | 466 | $7K | |
| 83525 | 702 | 694 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 293 | 239 | $7K |
| ATP02 | 2,385 | 2,082 | $7K | |
| 83721 | 1,209 | 1,154 | $7K | |
| 82550 | 3,524 | 3,192 | $7K | |
| 83718 | 896 | 896 | $7K | |
| ATP11 | 3,635 | 3,623 | $6K | |
| 82947 | 2,502 | 2,470 | $6K | |
| 87040 | 1,195 | 915 | $6K | |
| 84100 | 4,320 | 3,676 | $6K | |
| 87045 | 958 | 944 | $6K | |
| 84156 | 2,708 | 2,340 | $6K | |
| 86664 | 408 | 406 | $6K | |
| 83020 | 526 | 513 | $6K | |
| 85045 | 2,632 | 2,501 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 45 | 43 | $6K |
| ATP13 | 1,462 | 1,462 | $5K | |
| 83090 | 682 | 630 | $5K | |
| 86039 | 644 | 634 | $5K | |
| 86141 | 530 | 524 | $5K | |
| 84520 | 5,173 | 4,810 | $5K | |
| 80051 | 3,328 | 3,091 | $5K | |
| 82248 | 2,856 | 2,302 | $5K | |
| 84134 | 840 | 756 | $5K | |
| 83520 | 350 | 333 | $5K | |
| 80178 | 1,528 | 1,234 | $5K | |
| ATP07 | 1,827 | 1,781 | $4K | |
| 87329 | 472 | 471 | $4K | |
| 86300 | 418 | 355 | $4K | |
| 85018 | 2,253 | 2,063 | $4K | |
| 82310 | 2,389 | 2,231 | $4K | |
| 82951 | 360 | 358 | $4K | |
| 87324 | 682 | 664 | $4K | |
| 30100 | 553 | 185 | $4K | |
| 87449 | 683 | 661 | $4K | |
| 86231 | 516 | 500 | $4K | |
| 80069 | 2,054 | 1,784 | $4K | |
| 87184 | 913 | 841 | $3K | |
| ATP18 | 1,173 | 1,161 | $3K | |
| 84480 | 412 | 384 | $3K | |
| 80177 | 573 | 526 | $3K | |
| 85014 | 1,407 | 1,290 | $3K | |
| ATP05 | 631 | 627 | $2K | |
| 30200 | 81 | 54 | $2K | |
| 84484 | 441 | 420 | $2K | |
| 86256 | 213 | 210 | $2K | |
| ATP10 | 1,080 | 981 | $2K | |
| 84155 | 1,206 | 1,160 | $2K | |
| 87106 | 256 | 226 | $2K | |
| 87102 | 264 | 256 | $2K | |
| 81015 | 824 | 790 | $2K | |
| 86258 | 154 | 106 | $2K | |
| 87015 | 354 | 345 | $2K | |
| 84590 | 292 | 267 | $2K | |
| 85660 | 263 | 263 | $2K | |
| 82525 | 240 | 220 | $1K | |
| 86592 | 433 | 423 | $1K | |
| 86308 | 284 | 281 | $1K | |
| 85048 | 2,383 | 1,556 | $1K | |
| 83921 | 177 | 161 | $1K | |
| 82952 | 351 | 348 | $1K | |
| 87101 | 172 | 172 | $1K | |
| 82668 | 140 | 132 | $1K | |
| 86677 | 95 | 95 | $1K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 2,228 | 1,313 | $1K |
| 80185 | 379 | 288 | $1K | |
| ATP09 | 555 | 510 | $1K | |
| 84075 | 554 | 525 | $1K | |
| 84482 | 74 | 73 | $1K | |
| 84436 | 394 | 348 | $981.72 | |
| 86606 | 61 | 53 | $879.80 | |
| 84132 | 407 | 318 | $761.23 | |
| 80156 | 141 | 126 | $735.96 | |
| 86705 | 83 | 82 | $645.20 | |
| 86381 | 63 | 61 | $606.15 | |
| 89055 | 196 | 195 | $582.49 | |
| 86663 | 52 | 50 | $517.88 | |
| 86001 | 28 | 27 | $515.56 | |
| 84152 | 65 | 65 | $487.48 | |
| 83519 | 37 | 37 | $464.09 | |
| 86609 | 15 | 15 | $462.76 | |
| 84478 | 165 | 157 | $456.10 | |
| 80162 | 188 | 172 | $426.79 | |
| 86666 | 21 | 12 | $324.80 | |
| 84144 | 14 | 12 | $318.48 | |
| 86593 | 82 | 79 | $285.21 | |
| 82239 | 17 | 12 | $284.33 | |
| 81338 | 117 | 92 | $275.18 | |
| 82103 | 38 | 37 | $265.07 | |
| 85613 | 12 | 12 | $262.20 | |
| 87220 | 80 | 80 | $249.68 | |
| 86147 | 12 | 12 | $232.10 | |
| ATP04 | 94 | 86 | $232.08 | |
| 30000 | 99 | 39 | $205.77 | |
| ATP06 | 190 | 173 | $200.48 | |
| 84681 | 12 | 12 | $194.06 | |
| 82232 | 25 | 24 | $191.85 | |
| ATP16 | 49 | 39 | $141.87 | |
| 82330 | 14 | 14 | $115.80 | |
| 82553 | 26 | 25 | $108.12 | |
| 82955 | 12 | 12 | $101.72 | |
| 82270 | 23 | 22 | $74.52 | |
| ATP12 | 21 | 21 | $74.40 | |
| 89051 | 12 | 12 | $57.42 | |
| 80175 | 13 | 13 | $42.38 | |
| 30600 | 49 | 22 | $42.00 | |
| 81050 | 16 | 16 | $30.87 |